ORL · F/C · 9 seasons
| SEASON | TEAM | GP | MIN | FG | FG% | 3PT | 3P% | FT | FT% | OR | DR | REB | AST | BLK | STL | PF | TO | PTS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-19 | CHI | 44 | 25.2 | 4.1-8.4 | 48.5 | 0.1-0.7 | 18.8 | 2.0-2.5 | 79.5 | 2.0 | 5.0 | 7.0 | 1.8 | 1.3 | 0.6 | 3.5 | 1.5 | 10.3 |
| 2019-20 | CHI | 43 | 29.2 | 4.3-8.0 | 53.4 | 0.1-0.7 | 20.7 | 2.6-3.5 | 73.7 | 3.2 | 6.2 | 9.4 | 1.2 | 0.8 | 0.8 | 3.8 | 1.7 | 11.3 |
| 2020-21 | ORL | 54 | 25.5 | 4.3-8.5 | 50.3 | 0.3-0.9 | 29.4 | 2.4-3.3 | 73.2 | 2.4 | 5.8 | 8.2 | 1.9 | 0.8 | 0.6 | 2.7 | 1.4 | 11.2 |
| 2021-22 | ORL | 62 | 29.9 | 5.8-11.0 | 52.5 | 1.1-3.5 | 32.7 | 2.3-3.3 | 69.1 | 2.2 | 8.2 | 10.5 | 2.8 | 0.7 | 0.6 | 2.7 | 1.9 | 15.0 |
| 2022-23 | ORL | 57 | 29.6 | 5.6-10.8 | 52.5 | 1.4-3.9 | 35.6 | 2.5-3.4 | 73.8 | 2.1 | 6.6 | 8.7 | 2.3 | 0.6 | 0.5 | 2.8 | 1.9 | 15.2 |
| 2023-24 | ORL | 55 | 25.6 | 4.1-7.7 | 52.5 | 1.2-3.1 | 37.4 | 1.7-2.4 | 69.4 | 2.0 | 4.9 | 6.9 | 1.7 | 0.5 | 0.6 | 2.2 | 1.2 | 11.0 |
| 2024-25 | ORL | 68 | 25.9 | 3.3-7.2 | 46.0 | 0.5-2.3 | 23.4 | 1.9-2.6 | 73.7 | 2.2 | 5.0 | 7.2 | 2.0 | 0.6 | 0.8 | 2.9 | 1.1 | 9.1 |
| 2025-26 | ORL | 78 | 29.3 | 4.2-8.2 | 51.2 | 0.9-2.9 | 31.9 | 2.5-3.2 | 79.2 | 2.1 | 5.3 | 7.4 | 2.0 | 0.6 | 0.8 | 3.4 | 1.3 | 11.8 |
| 2026-27 | ORL | 9 | 33.5 | 5.1-8.1 | 63.0 | 1.2-2.6 | 47.8 | 3.3-4.6 | 73.2 | 2.8 | 6.8 | 9.6 | 1.0 | 0.7 | 1.1 | 3.3 | 1.9 | 14.8 |
| Career | 470 | 27.7 | 4.5-8.7 | 51.2 | 0.8-2.4 | 32.0 | 2.3-3.1 | 74.0 | 2.3 | 5.9 | 8.2 | 2.0 | 0.7 | 0.7 | 3.0 | 1.5 | 12.0 |
Games started is not in our data, so it is not a column here. Everything else is every regular season game he played.
What those averages were worth against the players around him that year. A season is its own league, so these do not add up across rows.
| SEASON | TEAM | FG% | FT% | 3PM | PTS | REB | AST | STL | BLK | TO | RANK |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-19 | CHI | +0.55 | +0.43 | -0.92 | +0.28 | +1.33 | -0.08 | -0.06 | +2.30 | -0.52 | 106 of 530 |
| 2019-20 | CHI | +1.29 | -0.43 | -0.93 | +0.40 | +2.34 | -0.42 | +0.37 | +1.07 | -0.67 | 117 of 529 |
| 2020-21 | ORL | +0.73 | -0.55 | -0.80 | +0.35 | +1.91 | -0.03 | +0.08 | +0.90 | -0.42 | 148 of 540 |
| 2021-22 | ORL | +1.51 | -1.17 | +0.25 | +1.07 | +2.92 | +0.49 | -0.06 | +0.87 | -1.06 | 79 of 605 |
| 2022-23 | ORL | +1.13 | -0.46 | +0.47 | +0.89 | +2.21 | +0.13 | -0.20 | +0.52 | -0.91 | 105 of 539 |
| 2023-24 | ORL | +0.92 | -0.98 | +0.25 | +0.37 | +1.47 | -0.15 | +0.12 | +0.27 | -0.32 | 163 of 572 |
| 2024-25 | ORL | +0.00 | -0.43 | -0.56 | +0.03 | +1.50 | -0.06 | +0.23 | +0.50 | -0.05 | 202 of 569 |
| 2025-26 | ORL | +0.74 | +0.19 | -0.14 | +0.42 | +1.63 | -0.09 | +0.17 | +0.60 | -0.20 | 119 of 582 |
| 2026-27 | ORL | +2.23 | -0.66 | +0.23 | +0.88 | +2.38 | -0.52 | +0.82 | +0.58 | -0.73 | 50 of 461 |